<DOC>
	<DOCNO>NCT00048997</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . It yet know give radiation therapy head effective preventing CNS metastases patient stage III non-small cell lung cancer . PURPOSE : This randomized phase III trial study well radiation therapy head work prevent CNS metastases patient previously treat stage III non-small cell lung cancer .</brief_summary>
	<brief_title>Radiation Therapy Preventing Central Nervous System ( CNS ) Metastases Patients With Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether prophylactic cranial irradiation improve survival effective locoregional/systemic therapy patient stage IIIA IIIB non-small cell lung cancer . - Determine neuropsychologic impact therapy patient . - Assess quality life patient receive therapy . - Determine impact therapy incidence CNS metastases patient . OUTLINE : This randomize , multicenter study . Patients stratify accord disease stage ( IIIA v IIIB ) , histology ( non-squamous cell vs squamous cell ) , prior surgery ( yes v ) . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo prophylactic cranial irradiation 5 day week 3 week . - Arm II : Patients undergo observation . Patients follow 3 month first year , every 6 month 2-3 year annually thereafter . Quality life assess baseline month 6 , 12 , 24 , 36 , 48 . PROJECTED ACCRUAL : A total 1,058 patient ( 529 per treatment arm ) accrue study within 36 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis stage IIIA IIIB nonsmall cell lung cancer Complete response , partial response , stable disease definitive locoregional therapy ( surgery and/or radiation therapy , without chemotherapy ( chemotherapy alone constitute definitive therapy ) ) No 16 week since prior therapy No progressive disease No extracranial distant metastatic disease No suspicion CNS metastases MRI CT scan PATIENT CHARACTERISTICS : Age 18 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No malignancy within past 3 year except nonmelanoma skin cancer Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy No concurrent anticancer biologic therapy Chemotherapy See Disease Characteristics No concurrent anticancer cytotoxic chemotherapy Endocrine therapy Not specify Radiotherapy See Disease Characteristics No prior cranial irradiation Surgery See Disease Characteristics Other Recovered prior therapy No concurrent enrollment phase III study progressionfree , diseasefree , overall survival endpoint</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
</DOC>